MARAVAI LIFESCIENCES HLDGS-A (MRVI)

US56600D1072 - Common Stock

5.33  +0.2 (+3.9%)

After market: 5.33 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
799.2M
181.31%
883M
10.49%
288.945M
-67.28%
264.64M
-8.41%
272.18M
2.85%
305.12M
12.10%
339.51M
11.27%
395.27M
16.42%
EBITDA
YoY % growth
568.1M
348.38%
606.1M
6.69%
15.072M
-97.51%
47.015M
211.94%
55.35M
17.73%
69.103M
24.85%
80.274M
16.17%
113.12M
40.92%
EBIT
YoY % growth
543.4M
438.55%
574.2M
5.67%
-25.182M
-104.39%
-2.95M
88.28%
9.527M
422.93%
31.229M
227.79%
98.94M
216.82%
126.48M
27.84%
Operating Margin
67.99%65.03%-8.72%-1.11%3.50%10.23%29.14%32.00%
EPS
YoY % growth
1.59
330.61%
1.80
13.21%
0.03
-98.33%
-0.08
-379.28%
-0.05
37.39%
0.01
115.56%
0.02
150.00%
0.14
600.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.04
-522.59%
-0.02
-15.92%
-0.02-0.01
35.08%
-0.01
73.45%
-0.04
-75.98%
-0.03
-94.05%
-0.02
-57.11%
-0.01
9.09%
Revenue
Q2Q % growth
57.781M
-22.07%
66.114M
3.02%
69.347M
-5.52%
70.035M
7.42%
70.489M
21.99%
58.63M
-11.32%
64.148M
-7.50%
69.697M
-0.48%
71.41M
1.31%
EBITDA
Q2Q % growth
6.337M
-83.99%
9.999M
218.78%
12.905M
-11.39%
13.323M
-36.97%
13.932M
119.85%
6.324M
-36.75%
10.343M
-19.85%
14.178M
6.42%
15.555M
11.65%
EBIT
Q2Q % growth
-4.142M
-505.59%
1.802M
108.98%
3.35M
135.20%
5.046M
133.91%
4.743M
214.50%
-7.273M
-503.58%
-3.335M
-199.56%
418.2K
-91.71%
1.856M
-60.87%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.02
-100.00%
-0.01-0.01-154.98%
Q2 2024
Q2Q % growth
0.00 0.000.00-100.00%
Q1 2024
Q2Q % growth
-0.02
-166.67%
-0.030.0122.99%
Q4 2023
Q2Q % growth
0.01
-97.14%
-0.010.02182.94%
Q3 2023
Q2Q % growth
-0.01
-102.70%
0.01-0.02-254.15%
Q2 2023
Q2Q % growth
0.00
-100.00%
0.01-0.01-100.00%
Q1 2023
Q2Q % growth
0.03
-94.44%
0.04-0.01-18.86%
Q4 2022
Q2Q % growth
0.35
-22.22%
0.350.000.38%
Q3 2022
Q2Q % growth
0.37
-15.91%
0.340.039.99%
Q2 2022
Q2Q % growth
0.54
22.73%
0.460.0816.50%
Q1 2022
Q2Q % growth
0.54
107.69%
0.450.0920.63%
Q4 2021
Q2Q % growth
0.45
246.15%
0.390.0614.76%
Q3 2021
Q2Q % growth
0.44 0.360.0822.47%
Q2 2021
Q2Q % growth
0.44 0.320.1236.25%
Q1 2021
Q2Q % growth
0.26 0.210.0524.10%
Q4 2020
Q2Q % growth
0.13 0.110.0217.90%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
65.2M
-2.49%
68.906M-3.706M-5.38%
Q2 2024
Q2Q % growth
73.4M
6.51%
73.067M333K0.46%
Q1 2024
Q2Q % growth
64.179M
-18.79%
61.759M2.42M3.92%
Q4 2023
Q2Q % growth
74.141M
-63.78%
65.667M8.474M12.90%
Q3 2023
Q2Q % growth
66.865M
-65.05%
77.034M-10.169M-13.20%
Q2 2023
Q2Q % growth
68.914M
-71.61%
72.548M-3.634M-5.01%
Q1 2023
Q2Q % growth
79.025M
-67.65%
81.315M-2.29M-2.82%
Q4 2022
Q2Q % growth
204.7M
-10.38%
209.03M-4.33M-2.07%
Q3 2022
Q2Q % growth
191.3M
-6.59%
199.01M-7.71M-3.87%
Q2 2022
Q2Q % growth
242.7M
11.43%
237.91M4.79M2.01%
Q1 2022
Q2Q % growth
244.3M
64.84%
236.94M7.36M3.11%
Q4 2021
Q2Q % growth
228.4M
132.11%
212.25M16.15M7.61%
Q3 2021
Q2Q % growth
204.8M
10.26%
205.53M-730K-0.36%
Q2 2021
Q2Q % growth
217.8M 198.71M19.09M9.61%
Q1 2021
Q2Q % growth
148.2M 141.26M6.94M4.91%
Q4 2020
Q2Q % growth
98.4M
173.33%
90.804M7.596M8.37%
Q3 2020
Q2Q % growth
185.745M
73.30%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.45% -810.63% -80.96% -154.22%
Revenue0% -20.56% -3.94% -5.86%